EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 2,880.00
+10.00 (0.35%)
At close: Sep 12, 2025
EyeGene Revenue
EyeGene had revenue of 877.31M KRW in the quarter ending June 30, 2025, with 56.27% growth. This brings the company's revenue in the last twelve months to 3.97B, up 39.61% year-over-year. In the year 2024, EyeGene had annual revenue of 3.36B with 7.37% growth.
Revenue (ttm)
3.97B
Revenue Growth
+39.61%
P/S Ratio
18.95
Revenue / Employee
84.38M
Employees
47
Market Cap
75.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36B | 230.37M | 7.37% |
| Dec 31, 2023 | 3.13B | -2.17B | -40.96% |
| Dec 31, 2022 | 5.29B | 2.05B | 63.27% |
| Dec 31, 2021 | 3.24B | -121.31M | -3.61% |
| Dec 31, 2020 | 3.36B | -881.96M | -20.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |